Mark Williams
Renal-replacement therapy options should be made available to patients because of the high incidence of chronic kidney disease (CKD) and the expanding number of persons with end-stage renal disease (ESRD) worldwide. Clinical studies have demonstrated the many advantages of peritoneal dialysis (PD) as a home-based dialysis therapy. These advantages include longer preservation of residual renal function, reduced hemodynamic stress, potential for improved patient survival, relatively high patient quality of life and a greater capacity to serve more ESRD patients due to its lower cost and infrastructure requirements.
分享此文章
English 
Spanish 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 